nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—MPO—Carboplatin—uterine cancer	0.375	0.652	CbGbCtD
Aminosalicylic Acid—PTGS2—Etoposide—uterine cancer	0.109	0.189	CbGbCtD
Aminosalicylic Acid—PTGS1—Etoposide—uterine cancer	0.0918	0.16	CbGbCtD
Aminosalicylic Acid—MPO—artery—uterine cancer	0.00769	0.0872	CbGeAlD
Aminosalicylic Acid—Abdominal bloating—Progesterone—uterine cancer	0.00615	0.0368	CcSEcCtD
Aminosalicylic Acid—Pericarditis—Medroxyprogesterone Acetate—uterine cancer	0.00613	0.0367	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—AKR1C1—uterine cancer	0.00613	1	CrCbGaD
Aminosalicylic Acid—CHUK—epithelium—uterine cancer	0.00612	0.0694	CbGeAlD
Aminosalicylic Acid—CHUK—renal system—uterine cancer	0.00567	0.0643	CbGeAlD
Aminosalicylic Acid—Abdominal bloating—Medroxyprogesterone Acetate—uterine cancer	0.00557	0.0334	CcSEcCtD
Aminosalicylic Acid—PTGS1—oviduct—uterine cancer	0.00551	0.0625	CbGeAlD
Aminosalicylic Acid—Optic neuritis—Progesterone—uterine cancer	0.00476	0.0285	CcSEcCtD
Aminosalicylic Acid—CHUK—female reproductive system—uterine cancer	0.00454	0.0515	CbGeAlD
Aminosalicylic Acid—Optic neuritis—Medroxyprogesterone Acetate—uterine cancer	0.00431	0.0258	CcSEcCtD
Aminosalicylic Acid—CHUK—female gonad—uterine cancer	0.00413	0.0469	CbGeAlD
Aminosalicylic Acid—Hypothyroidism—Medroxyprogesterone Acetate—uterine cancer	0.00413	0.0247	CcSEcCtD
Aminosalicylic Acid—PTGS1—artery—uterine cancer	0.00365	0.0414	CbGeAlD
Aminosalicylic Acid—PTGS2—artery—uterine cancer	0.00349	0.0395	CbGeAlD
Aminosalicylic Acid—Eruption—Dactinomycin—uterine cancer	0.00336	0.0201	CcSEcCtD
Aminosalicylic Acid—ALOX5—smooth muscle tissue—uterine cancer	0.00332	0.0377	CbGeAlD
Aminosalicylic Acid—ALOX5—decidua—uterine cancer	0.00325	0.0369	CbGeAlD
Aminosalicylic Acid—MPO—epithelium—uterine cancer	0.00291	0.0331	CbGeAlD
Aminosalicylic Acid—MPO—renal system—uterine cancer	0.0027	0.0307	CbGeAlD
Aminosalicylic Acid—CHUK—lymph node—uterine cancer	0.00266	0.0301	CbGeAlD
Aminosalicylic Acid—ALOX5—female reproductive system—uterine cancer	0.00256	0.029	CbGeAlD
Aminosalicylic Acid—Optic neuritis—Etoposide—uterine cancer	0.00243	0.0146	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Progesterone—uterine cancer	0.00237	0.0142	CcSEcCtD
Aminosalicylic Acid—ALOX5—female gonad—uterine cancer	0.00233	0.0264	CbGeAlD
Aminosalicylic Acid—Purpura—Progesterone—uterine cancer	0.0022	0.0132	CcSEcCtD
Aminosalicylic Acid—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00213	0.0128	CcSEcCtD
Aminosalicylic Acid—Purpura—Medroxyprogesterone Acetate—uterine cancer	0.002	0.012	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00197	0.0118	CcSEcCtD
Aminosalicylic Acid—Pericarditis—Epirubicin—uterine cancer	0.00194	0.0116	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Progesterone—uterine cancer	0.00185	0.0111	CcSEcCtD
Aminosalicylic Acid—Pericarditis—Doxorubicin—uterine cancer	0.0018	0.0108	CcSEcCtD
Aminosalicylic Acid—PTGS2—myometrium—uterine cancer	0.00168	0.0191	CbGeAlD
Aminosalicylic Acid—Abdominal distension—Medroxyprogesterone Acetate—uterine cancer	0.00167	0.01	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Progesterone—uterine cancer	0.00166	0.00995	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Progesterone—uterine cancer	0.0016	0.00961	CcSEcCtD
Aminosalicylic Acid—Jaundice—Progesterone—uterine cancer	0.0016	0.00956	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Carboplatin—uterine cancer	0.00157	0.00941	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Medroxyprogesterone Acetate—uterine cancer	0.00151	0.00901	CcSEcCtD
Aminosalicylic Acid—ALOX5—lymph node—uterine cancer	0.0015	0.017	CbGeAlD
Aminosalicylic Acid—Hepatitis—Progesterone—uterine cancer	0.00147	0.0088	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00145	0.00871	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Progesterone—uterine cancer	0.00145	0.00869	CcSEcCtD
Aminosalicylic Acid—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00145	0.00866	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Progesterone—uterine cancer	0.00144	0.00863	CcSEcCtD
Aminosalicylic Acid—PTGS1—epithelium—uterine cancer	0.00138	0.0157	CbGeAlD
Aminosalicylic Acid—PTGS1—uterine cervix—uterine cancer	0.00137	0.0156	CbGeAlD
Aminosalicylic Acid—Optic neuritis—Epirubicin—uterine cancer	0.00136	0.00817	CcSEcCtD
Aminosalicylic Acid—Eruption—Epirubicin—uterine cancer	0.00136	0.00817	CcSEcCtD
Aminosalicylic Acid—PTGS1—smooth muscle tissue—uterine cancer	0.00133	0.0151	CbGeAlD
Aminosalicylic Acid—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.00133	0.00797	CcSEcCtD
Aminosalicylic Acid—PTGS2—epithelium—uterine cancer	0.00132	0.015	CbGeAlD
Aminosalicylic Acid—Urinary tract disorder—Medroxyprogesterone Acetate—uterine cancer	0.00132	0.00788	CcSEcCtD
Aminosalicylic Acid—PTGS2—uterine cervix—uterine cancer	0.00131	0.0149	CbGeAlD
Aminosalicylic Acid—Urethral disorder—Medroxyprogesterone Acetate—uterine cancer	0.00131	0.00782	CcSEcCtD
Aminosalicylic Acid—PTGS1—renal system—uterine cancer	0.00128	0.0145	CbGeAlD
Aminosalicylic Acid—Malnutrition—Progesterone—uterine cancer	0.00128	0.00766	CcSEcCtD
Aminosalicylic Acid—PTGS2—smooth muscle tissue—uterine cancer	0.00127	0.0144	CbGeAlD
Aminosalicylic Acid—MPO—lymph node—uterine cancer	0.00127	0.0144	CbGeAlD
Aminosalicylic Acid—Optic neuritis—Doxorubicin—uterine cancer	0.00126	0.00756	CcSEcCtD
Aminosalicylic Acid—Eruption—Doxorubicin—uterine cancer	0.00126	0.00756	CcSEcCtD
Aminosalicylic Acid—Flatulence—Progesterone—uterine cancer	0.00126	0.00755	CcSEcCtD
Aminosalicylic Acid—PTGS1—endometrium—uterine cancer	0.00124	0.0141	CbGeAlD
Aminosalicylic Acid—PTGS2—renal system—uterine cancer	0.00123	0.0139	CbGeAlD
Aminosalicylic Acid—PTGS1—mammalian vulva—uterine cancer	0.0012	0.0136	CbGeAlD
Aminosalicylic Acid—PTGS2—endometrium—uterine cancer	0.00119	0.0134	CbGeAlD
Aminosalicylic Acid—Anaemia—Progesterone—uterine cancer	0.00118	0.00708	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00694	CcSEcCtD
Aminosalicylic Acid—PTGS1—uterus—uterine cancer	0.00114	0.013	CbGeAlD
Aminosalicylic Acid—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.00684	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.0068	CcSEcCtD
Aminosalicylic Acid—Dermatitis atopic—Epirubicin—uterine cancer	0.00113	0.00679	CcSEcCtD
Aminosalicylic Acid—PTGS2—uterus—uterine cancer	0.00109	0.0124	CbGeAlD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00108	0.00648	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Dactinomycin—uterine cancer	0.00108	0.00647	CcSEcCtD
Aminosalicylic Acid—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00107	0.00642	CcSEcCtD
Aminosalicylic Acid—Dermatitis atopic—Doxorubicin—uterine cancer	0.00105	0.00628	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Dactinomycin—uterine cancer	0.00104	0.00622	CcSEcCtD
Aminosalicylic Acid—PTGS1—female reproductive system—uterine cancer	0.00103	0.0117	CbGeAlD
Aminosalicylic Acid—Nervous system disorder—Progesterone—uterine cancer	0.00102	0.00613	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Progesterone—uterine cancer	0.00101	0.00607	CcSEcCtD
Aminosalicylic Acid—Anorexia—Progesterone—uterine cancer	0.000995	0.00596	CcSEcCtD
Aminosalicylic Acid—PTGS2—female reproductive system—uterine cancer	0.000982	0.0111	CbGeAlD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00098	0.00587	CcSEcCtD
Aminosalicylic Acid—PTGS1—female gonad—uterine cancer	0.000935	0.0106	CbGeAlD
Aminosalicylic Acid—PTGS1—vagina—uterine cancer	0.000929	0.0105	CbGeAlD
Aminosalicylic Acid—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000928	0.00556	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000926	0.00555	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000919	0.0055	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Progesterone—uterine cancer	0.000908	0.00544	CcSEcCtD
Aminosalicylic Acid—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000902	0.0054	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Progesterone—uterine cancer	0.000901	0.0054	CcSEcCtD
Aminosalicylic Acid—PTGS2—female gonad—uterine cancer	0.000893	0.0101	CbGeAlD
Aminosalicylic Acid—PTGS2—vagina—uterine cancer	0.000888	0.0101	CbGeAlD
Aminosalicylic Acid—Gastrointestinal pain—Progesterone—uterine cancer	0.000854	0.00511	CcSEcCtD
Aminosalicylic Acid—Anaemia—Dactinomycin—uterine cancer	0.000836	0.005	CcSEcCtD
Aminosalicylic Acid—Urticaria—Progesterone—uterine cancer	0.000829	0.00497	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Progesterone—uterine cancer	0.000825	0.00494	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Progesterone—uterine cancer	0.000825	0.00494	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000822	0.00492	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Etoposide—uterine cancer	0.000821	0.00492	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000817	0.00489	CcSEcCtD
Aminosalicylic Acid—Jaundice—Etoposide—uterine cancer	0.000816	0.00489	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Dactinomycin—uterine cancer	0.000809	0.00485	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Etoposide—uterine cancer	0.000781	0.00468	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000774	0.00463	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Progesterone—uterine cancer	0.000769	0.00461	CcSEcCtD
Aminosalicylic Acid—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000752	0.0045	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000748	0.00448	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000748	0.00448	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Etoposide—uterine cancer	0.000742	0.00445	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Etoposide—uterine cancer	0.000737	0.00441	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Dactinomycin—uterine cancer	0.000723	0.00433	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Progesterone—uterine cancer	0.000714	0.00428	CcSEcCtD
Aminosalicylic Acid—Anorexia—Dactinomycin—uterine cancer	0.000703	0.00421	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000697	0.00417	CcSEcCtD
Aminosalicylic Acid—Dizziness—Progesterone—uterine cancer	0.00069	0.00413	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Epirubicin—uterine cancer	0.000681	0.00408	CcSEcCtD
Aminosalicylic Acid—Vomiting—Progesterone—uterine cancer	0.000664	0.00398	CcSEcCtD
Aminosalicylic Acid—Rash—Progesterone—uterine cancer	0.000658	0.00394	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Progesterone—uterine cancer	0.000658	0.00394	CcSEcCtD
Aminosalicylic Acid—Headache—Progesterone—uterine cancer	0.000654	0.00392	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000647	0.00388	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Epirubicin—uterine cancer	0.000646	0.00387	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Dactinomycin—uterine cancer	0.000641	0.00384	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Etoposide—uterine cancer	0.000641	0.00384	CcSEcCtD
Aminosalicylic Acid—Purpura—Epirubicin—uterine cancer	0.000632	0.00378	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Doxorubicin—uterine cancer	0.00063	0.00377	CcSEcCtD
Aminosalicylic Acid—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000626	0.00375	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Epirubicin—uterine cancer	0.000624	0.00374	CcSEcCtD
Aminosalicylic Acid—Nausea—Progesterone—uterine cancer	0.00062	0.00371	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000609	0.00365	CcSEcCtD
Aminosalicylic Acid—Anaemia—Etoposide—uterine cancer	0.000605	0.00362	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000603	0.00361	CcSEcCtD
Aminosalicylic Acid—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000602	0.0036	CcSEcCtD
Aminosalicylic Acid—PTGS1—lymph node—uterine cancer	0.000601	0.00682	CbGeAlD
Aminosalicylic Acid—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000597	0.00358	CcSEcCtD
Aminosalicylic Acid—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000597	0.00357	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000596	0.00357	CcSEcCtD
Aminosalicylic Acid—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000593	0.00355	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Etoposide—uterine cancer	0.000586	0.00351	CcSEcCtD
Aminosalicylic Acid—Purpura—Doxorubicin—uterine cancer	0.000585	0.0035	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Dactinomycin—uterine cancer	0.000583	0.00349	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Dactinomycin—uterine cancer	0.000583	0.00349	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Doxorubicin—uterine cancer	0.000578	0.00346	CcSEcCtD
Aminosalicylic Acid—PTGS2—lymph node—uterine cancer	0.000574	0.00651	CbGeAlD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000564	0.00338	CcSEcCtD
Aminosalicylic Acid—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000562	0.00337	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000553	0.00331	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Dactinomycin—uterine cancer	0.000544	0.00326	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Epirubicin—uterine cancer	0.00053	0.00317	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Etoposide—uterine cancer	0.000523	0.00313	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Etoposide—uterine cancer	0.000519	0.00311	CcSEcCtD
Aminosalicylic Acid—Anorexia—Etoposide—uterine cancer	0.000509	0.00305	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Dactinomycin—uterine cancer	0.000505	0.00302	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Doxorubicin—uterine cancer	0.00049	0.00294	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Epirubicin—uterine cancer	0.000476	0.00285	CcSEcCtD
Aminosalicylic Acid—Vomiting—Dactinomycin—uterine cancer	0.000469	0.00281	CcSEcCtD
Aminosalicylic Acid—Rash—Dactinomycin—uterine cancer	0.000465	0.00279	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Etoposide—uterine cancer	0.000464	0.00278	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Etoposide—uterine cancer	0.000461	0.00276	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Epirubicin—uterine cancer	0.00046	0.00276	CcSEcCtD
Aminosalicylic Acid—Jaundice—Epirubicin—uterine cancer	0.000458	0.00274	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Doxorubicin—uterine cancer	0.000441	0.00264	CcSEcCtD
Aminosalicylic Acid—Nausea—Dactinomycin—uterine cancer	0.000438	0.00262	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Epirubicin—uterine cancer	0.000438	0.00262	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Etoposide—uterine cancer	0.000437	0.00262	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000426	0.00255	CcSEcCtD
Aminosalicylic Acid—Urticaria—Etoposide—uterine cancer	0.000424	0.00254	CcSEcCtD
Aminosalicylic Acid—Jaundice—Doxorubicin—uterine cancer	0.000423	0.00254	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Etoposide—uterine cancer	0.000422	0.00253	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Etoposide—uterine cancer	0.000422	0.00253	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Epirubicin—uterine cancer	0.000421	0.00252	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Epirubicin—uterine cancer	0.000416	0.00249	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Epirubicin—uterine cancer	0.000413	0.00247	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Doxorubicin—uterine cancer	0.000405	0.00243	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Etoposide—uterine cancer	0.000393	0.00236	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Doxorubicin—uterine cancer	0.00039	0.00233	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Doxorubicin—uterine cancer	0.000385	0.00231	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Doxorubicin—uterine cancer	0.000382	0.00229	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Epirubicin—uterine cancer	0.000367	0.0022	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Etoposide—uterine cancer	0.000365	0.00219	CcSEcCtD
Aminosalicylic Acid—Flatulence—Epirubicin—uterine cancer	0.000361	0.00216	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Epirubicin—uterine cancer	0.000359	0.00215	CcSEcCtD
Aminosalicylic Acid—Dizziness—Etoposide—uterine cancer	0.000353	0.00212	CcSEcCtD
Aminosalicylic Acid—Vomiting—Etoposide—uterine cancer	0.00034	0.00203	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Doxorubicin—uterine cancer	0.000339	0.00203	CcSEcCtD
Aminosalicylic Acid—Anaemia—Epirubicin—uterine cancer	0.000339	0.00203	CcSEcCtD
Aminosalicylic Acid—Rash—Etoposide—uterine cancer	0.000337	0.00202	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Etoposide—uterine cancer	0.000336	0.00201	CcSEcCtD
Aminosalicylic Acid—Headache—Etoposide—uterine cancer	0.000335	0.002	CcSEcCtD
Aminosalicylic Acid—Flatulence—Doxorubicin—uterine cancer	0.000334	0.002	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Doxorubicin—uterine cancer	0.000332	0.00199	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Epirubicin—uterine cancer	0.000328	0.00197	CcSEcCtD
Aminosalicylic Acid—Nausea—Etoposide—uterine cancer	0.000317	0.0019	CcSEcCtD
Aminosalicylic Acid—Anaemia—Doxorubicin—uterine cancer	0.000314	0.00188	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.00031	0.00186	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Doxorubicin—uterine cancer	0.000304	0.00182	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Epirubicin—uterine cancer	0.000294	0.00176	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Epirubicin—uterine cancer	0.000293	0.00176	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Epirubicin—uterine cancer	0.000291	0.00174	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000287	0.00172	CcSEcCtD
Aminosalicylic Acid—Anorexia—Epirubicin—uterine cancer	0.000285	0.00171	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Doxorubicin—uterine cancer	0.000272	0.00163	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Doxorubicin—uterine cancer	0.000271	0.00162	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Doxorubicin—uterine cancer	0.000269	0.00161	CcSEcCtD
Aminosalicylic Acid—Anorexia—Doxorubicin—uterine cancer	0.000264	0.00158	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Epirubicin—uterine cancer	0.00026	0.00156	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000258	0.00155	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Epirubicin—uterine cancer	0.000245	0.00147	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Doxorubicin—uterine cancer	0.000241	0.00144	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000239	0.00143	CcSEcCtD
Aminosalicylic Acid—Urticaria—Epirubicin—uterine cancer	0.000238	0.00142	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Epirubicin—uterine cancer	0.000237	0.00142	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Epirubicin—uterine cancer	0.000237	0.00142	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000227	0.00136	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Epirubicin—uterine cancer	0.000221	0.00132	CcSEcCtD
Aminosalicylic Acid—Urticaria—Doxorubicin—uterine cancer	0.00022	0.00132	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Doxorubicin—uterine cancer	0.000219	0.00131	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Doxorubicin—uterine cancer	0.000219	0.00131	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Epirubicin—uterine cancer	0.000205	0.00123	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Doxorubicin—uterine cancer	0.000204	0.00122	CcSEcCtD
Aminosalicylic Acid—Dizziness—Epirubicin—uterine cancer	0.000198	0.00119	CcSEcCtD
Aminosalicylic Acid—Vomiting—Epirubicin—uterine cancer	0.00019	0.00114	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Doxorubicin—uterine cancer	0.00019	0.00114	CcSEcCtD
Aminosalicylic Acid—Rash—Epirubicin—uterine cancer	0.000189	0.00113	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Epirubicin—uterine cancer	0.000189	0.00113	CcSEcCtD
Aminosalicylic Acid—Headache—Epirubicin—uterine cancer	0.000188	0.00112	CcSEcCtD
Aminosalicylic Acid—Dizziness—Doxorubicin—uterine cancer	0.000183	0.0011	CcSEcCtD
Aminosalicylic Acid—Nausea—Epirubicin—uterine cancer	0.000178	0.00106	CcSEcCtD
Aminosalicylic Acid—Vomiting—Doxorubicin—uterine cancer	0.000176	0.00105	CcSEcCtD
Aminosalicylic Acid—Rash—Doxorubicin—uterine cancer	0.000175	0.00105	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Doxorubicin—uterine cancer	0.000174	0.00104	CcSEcCtD
Aminosalicylic Acid—Headache—Doxorubicin—uterine cancer	0.000174	0.00104	CcSEcCtD
Aminosalicylic Acid—Nausea—Doxorubicin—uterine cancer	0.000165	0.000985	CcSEcCtD
Aminosalicylic Acid—CHUK—DAP12 signaling—KRAS—uterine cancer	0.000113	0.000693	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—PIK3CA—uterine cancer	0.000112	0.000688	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—KRAS—uterine cancer	0.000112	0.000683	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—ERBB2—uterine cancer	0.000111	0.000679	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—PIK3CA—uterine cancer	0.00011	0.000677	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—NRAS—uterine cancer	0.00011	0.000671	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—HRAS—uterine cancer	0.000109	0.000665	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NDUFB11—uterine cancer	0.000108	0.000662	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SRD5A2—uterine cancer	0.000108	0.000662	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—TP53—uterine cancer	0.000107	0.000658	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—HRAS—uterine cancer	0.000107	0.000654	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—PTEN—uterine cancer	0.000107	0.000653	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—KRAS—uterine cancer	0.000106	0.000652	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—KRAS—uterine cancer	0.000106	0.000652	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—KRAS—uterine cancer	0.000106	0.000652	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—PIK3CA—uterine cancer	0.000106	0.000647	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—KRAS—uterine cancer	0.000106	0.000647	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—PIK3CA—uterine cancer	0.000105	0.000643	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000105	0.000643	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—KRAS—uterine cancer	0.000105	0.000641	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—PIK3CA—uterine cancer	0.000104	0.00064	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—KRAS—uterine cancer	0.000104	0.000638	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—PIK3CA—uterine cancer	0.000104	0.000637	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—HRAS—uterine cancer	0.000104	0.000636	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—CDKN1B—uterine cancer	0.000103	0.000629	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—uterine cancer	0.000102	0.000628	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—HRAS—uterine cancer	0.000102	0.000626	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—EP300—uterine cancer	0.000102	0.000623	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—FGFR2—uterine cancer	0.000101	0.000616	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKR1B10—uterine cancer	0.0001	0.000615	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	0.0001	0.000614	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—DCN—uterine cancer	0.0001	0.000613	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—STK11—uterine cancer	9.99e-05	0.000612	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CYP19A1—uterine cancer	9.99e-05	0.000612	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	9.91e-05	0.000607	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—KRAS—uterine cancer	9.85e-05	0.000604	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AKR1B1—uterine cancer	9.84e-05	0.000603	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—STAR—uterine cancer	9.84e-05	0.000603	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RNF43—uterine cancer	9.83e-05	0.000602	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—PIK3CA—uterine cancer	9.78e-05	0.000599	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—PIK3CA—uterine cancer	9.78e-05	0.000599	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—PIK3CA—uterine cancer	9.78e-05	0.000599	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—HRAS—uterine cancer	9.76e-05	0.000598	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—HRAS—uterine cancer	9.73e-05	0.000596	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	9.72e-05	0.000596	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—HRAS—uterine cancer	9.71e-05	0.000595	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—AKT1—uterine cancer	9.69e-05	0.000594	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—PIK3CA—uterine cancer	9.69e-05	0.000594	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—HRAS—uterine cancer	9.67e-05	0.000592	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—FGFR2—uterine cancer	9.66e-05	0.000592	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—HRAS—uterine cancer	9.62e-05	0.000589	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—PIK3CA—uterine cancer	9.61e-05	0.000589	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—AKT1—uterine cancer	9.58e-05	0.000587	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IRF1—uterine cancer	9.58e-05	0.000587	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—PIK3CA—uterine cancer	9.57e-05	0.000586	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—uterine cancer	9.48e-05	0.000581	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—PTEN—uterine cancer	9.45e-05	0.000579	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—KRAS—uterine cancer	9.43e-05	0.000578	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—AKT1—uterine cancer	9.42e-05	0.000577	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.37e-05	0.000574	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	9.2e-05	0.000564	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—AKT1—uterine cancer	9.17e-05	0.000562	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—AKT1—uterine cancer	9.07e-05	0.000556	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	9.06e-05	0.000555	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—PIK3CA—uterine cancer	9.05e-05	0.000555	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—uterine cancer	9.05e-05	0.000555	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—HRAS—uterine cancer	9.05e-05	0.000555	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—HRAS—uterine cancer	9.05e-05	0.000555	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—AKT1—uterine cancer	9.03e-05	0.000553	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—INHBA—uterine cancer	8.99e-05	0.000551	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—HRAS—uterine cancer	8.97e-05	0.00055	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.94e-05	0.000548	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	8.9e-05	0.000546	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—AKR1C3—uterine cancer	8.9e-05	0.000545	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—HRAS—uterine cancer	8.89e-05	0.000545	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—HRAS—uterine cancer	8.85e-05	0.000542	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HMGA1—uterine cancer	8.67e-05	0.000531	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—PIK3CA—uterine cancer	8.66e-05	0.000531	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—AKT1—uterine cancer	8.62e-05	0.000528	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FBXW7—uterine cancer	8.59e-05	0.000526	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—AKT1—uterine cancer	8.58e-05	0.000526	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—NRAS—uterine cancer	8.57e-05	0.000525	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—AKT1—uterine cancer	8.54e-05	0.000523	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—AKT1—uterine cancer	8.49e-05	0.00052	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—NRAS—uterine cancer	8.43e-05	0.000516	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	8.39e-05	0.000514	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—HRAS—uterine cancer	8.37e-05	0.000513	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—uterine cancer	8.37e-05	0.000513	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—RNF43—uterine cancer	8.31e-05	0.000509	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKR1C1—uterine cancer	8.09e-05	0.000496	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—uterine cancer	8.02e-05	0.000491	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—AKT1—uterine cancer	7.99e-05	0.00049	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—AKT1—uterine cancer	7.99e-05	0.00049	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—AKT1—uterine cancer	7.99e-05	0.00049	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	7.93e-05	0.000486	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—FBXW7—uterine cancer	7.93e-05	0.000486	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—AKT1—uterine cancer	7.92e-05	0.000485	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—AKT1—uterine cancer	7.85e-05	0.000481	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—AKT1—uterine cancer	7.81e-05	0.000479	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AKR1B1—uterine cancer	7.81e-05	0.000479	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—STAR—uterine cancer	7.81e-05	0.000479	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TP53—uterine cancer	7.75e-05	0.000475	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	7.73e-05	0.000474	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—POLD1—uterine cancer	7.72e-05	0.000473	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	7.72e-05	0.000473	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	7.52e-05	0.000461	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—PIK3CA—uterine cancer	7.52e-05	0.00046	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—MTHFR—uterine cancer	7.5e-05	0.00046	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—AKT1—uterine cancer	7.39e-05	0.000453	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—KRAS—uterine cancer	7.38e-05	0.000452	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	7.37e-05	0.000452	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—KRAS—uterine cancer	7.25e-05	0.000444	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AKR1C1—uterine cancer	7.22e-05	0.000442	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CDH1—uterine cancer	7.19e-05	0.000441	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—uterine cancer	7.08e-05	0.000434	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—SOCS3—uterine cancer	7.03e-05	0.000431	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	6.98e-05	0.000428	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKR1C1—uterine cancer	6.84e-05	0.000419	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—PIK3CA—uterine cancer	6.78e-05	0.000415	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—PIK3CA—uterine cancer	6.66e-05	0.000408	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.61e-05	0.000405	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—RRM2—uterine cancer	6.44e-05	0.000394	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—ERBB2—uterine cancer	6.32e-05	0.000387	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HRAS—uterine cancer	6.27e-05	0.000384	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—DCN—uterine cancer	6.25e-05	0.000383	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKR1C3—uterine cancer	6.23e-05	0.000382	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CDKN2B—uterine cancer	6.21e-05	0.000381	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—HRAS—uterine cancer	6.16e-05	0.000378	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—AKT1—uterine cancer	6.14e-05	0.000376	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—POLD1—uterine cancer	6.13e-05	0.000375	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PGR—uterine cancer	6.07e-05	0.000372	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—ERBB2—uterine cancer	6.07e-05	0.000372	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	5.93e-05	0.000364	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—DCN—uterine cancer	5.92e-05	0.000363	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP11A1—uterine cancer	5.89e-05	0.000361	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FGFR2—uterine cancer	5.86e-05	0.000359	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CDKN1B—uterine cancer	5.85e-05	0.000358	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—YWHAE—uterine cancer	5.79e-05	0.000355	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AKR1C1—uterine cancer	5.73e-05	0.000351	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SMAD3—uterine cancer	5.67e-05	0.000348	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CDKN1B—uterine cancer	5.62e-05	0.000344	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AKR1C3—uterine cancer	5.56e-05	0.000341	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FBXW7—uterine cancer	5.55e-05	0.00034	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CTNNB1—uterine cancer	5.53e-05	0.000339	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	5.45e-05	0.000334	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—AKT1—uterine cancer	5.44e-05	0.000334	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—FGFR2—uterine cancer	5.41e-05	0.000331	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PTEN—uterine cancer	5.39e-05	0.00033	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	5.27e-05	0.000323	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKR1C3—uterine cancer	5.27e-05	0.000323	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MTHFR—uterine cancer	5.21e-05	0.000319	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PTEN—uterine cancer	5.17e-05	0.000317	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—EP300—uterine cancer	5.14e-05	0.000315	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HMGA1—uterine cancer	5.13e-05	0.000315	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—RRM2—uterine cancer	5.11e-05	0.000313	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—DCN—uterine cancer	4.96e-05	0.000304	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—STK11—uterine cancer	4.85e-05	0.000297	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—NRAS—uterine cancer	4.81e-05	0.000295	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FBXW7—uterine cancer	4.7e-05	0.000288	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP11A1—uterine cancer	4.67e-05	0.000286	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—NRAS—uterine cancer	4.62e-05	0.000283	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SOCS3—uterine cancer	4.54e-05	0.000278	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	4.45e-05	0.000273	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AKR1C3—uterine cancer	4.41e-05	0.00027	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CDH1—uterine cancer	4.36e-05	0.000267	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CDKN2B—uterine cancer	4.35e-05	0.000267	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP19A1—uterine cancer	4.33e-05	0.000265	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—STK11—uterine cancer	4.33e-05	0.000265	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IGF1R—uterine cancer	4.22e-05	0.000259	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTEN—uterine cancer	4.17e-05	0.000256	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—KRAS—uterine cancer	4.14e-05	0.000253	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.06e-05	0.000249	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—EP300—uterine cancer	3.98e-05	0.000244	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—KRAS—uterine cancer	3.97e-05	0.000243	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SMAD3—uterine cancer	3.97e-05	0.000243	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.88e-05	0.000238	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PIK3CA—uterine cancer	3.8e-05	0.000233	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGFR2—uterine cancer	3.79e-05	0.000232	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CDKN2B—uterine cancer	3.68e-05	0.000225	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ERBB2—uterine cancer	3.68e-05	0.000225	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PIK3CA—uterine cancer	3.65e-05	0.000224	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—HRAS—uterine cancer	3.52e-05	0.000215	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—STK11—uterine cancer	3.44e-05	0.000211	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP19A1—uterine cancer	3.44e-05	0.000211	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CDKN1B—uterine cancer	3.41e-05	0.000209	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—ERBB2—uterine cancer	3.4e-05	0.000208	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HRAS—uterine cancer	3.38e-05	0.000207	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SMAD3—uterine cancer	3.36e-05	0.000206	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—MTHFR—uterine cancer	3.25e-05	0.000199	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ESR1—uterine cancer	3.24e-05	0.000199	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.23e-05	0.000198	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CTNNB1—uterine cancer	3.22e-05	0.000197	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGFR2—uterine cancer	3.2e-05	0.000196	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CDKN1B—uterine cancer	3.15e-05	0.000193	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PTEN—uterine cancer	3.14e-05	0.000192	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—AKT1—uterine cancer	3.1e-05	0.00019	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MTHFR—uterine cancer	3.08e-05	0.000189	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.08e-05	0.000189	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—EP300—uterine cancer	2.99e-05	0.000183	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—AKT1—uterine cancer	2.98e-05	0.000183	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CTNNB1—uterine cancer	2.97e-05	0.000182	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PIK3CA—uterine cancer	2.95e-05	0.00018	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTEN—uterine cancer	2.9e-05	0.000178	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.87e-05	0.000176	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCL2—uterine cancer	2.85e-05	0.000175	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—NRAS—uterine cancer	2.8e-05	0.000172	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—EP300—uterine cancer	2.76e-05	0.000169	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NRAS—uterine cancer	2.58e-05	0.000158	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—MTHFR—uterine cancer	2.58e-05	0.000158	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—KRAS—uterine cancer	2.41e-05	0.000148	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—AKT1—uterine cancer	2.41e-05	0.000147	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ERBB2—uterine cancer	2.38e-05	0.000146	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.28e-05	0.000139	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCL8—uterine cancer	2.26e-05	0.000138	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—KRAS—uterine cancer	2.22e-05	0.000136	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PIK3CA—uterine cancer	2.21e-05	0.000136	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CDKN1B—uterine cancer	2.2e-05	0.000135	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CTNNB1—uterine cancer	2.08e-05	0.000128	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HRAS—uterine cancer	2.05e-05	0.000125	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PIK3CA—uterine cancer	2.04e-05	0.000125	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTEN—uterine cancer	2.03e-05	0.000124	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ERBB2—uterine cancer	2.01e-05	0.000123	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EP300—uterine cancer	1.93e-05	0.000119	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HRAS—uterine cancer	1.89e-05	0.000116	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CDKN1B—uterine cancer	1.86e-05	0.000114	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VEGFA—uterine cancer	1.83e-05	0.000112	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTEN—uterine cancer	1.81e-05	0.000111	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NRAS—uterine cancer	1.81e-05	0.000111	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—AKT1—uterine cancer	1.81e-05	0.000111	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CTNNB1—uterine cancer	1.76e-05	0.000108	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—EP300—uterine cancer	1.73e-05	0.000106	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PTEN—uterine cancer	1.72e-05	0.000105	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—AKT1—uterine cancer	1.67e-05	0.000102	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—EP300—uterine cancer	1.64e-05	0.0001	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KRAS—uterine cancer	1.56e-05	9.54e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NRAS—uterine cancer	1.53e-05	9.38e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PTEN—uterine cancer	1.44e-05	8.81e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CA—uterine cancer	1.43e-05	8.77e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TP53—uterine cancer	1.38e-05	8.48e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—EP300—uterine cancer	1.37e-05	8.4e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HRAS—uterine cancer	1.32e-05	8.11e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—KRAS—uterine cancer	1.32e-05	8.07e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CA—uterine cancer	1.28e-05	7.83e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PIK3CA—uterine cancer	1.21e-05	7.42e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKT1—uterine cancer	1.17e-05	7.16e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HRAS—uterine cancer	1.12e-05	6.86e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AKT1—uterine cancer	1.04e-05	6.39e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CA—uterine cancer	1.01e-05	6.21e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKT1—uterine cancer	9.89e-06	6.06e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AKT1—uterine cancer	8.28e-06	5.07e-05	CbGpPWpGaD
